Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Receives $18.38 Average Target Price from Analysts

Shares of Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) have been given an average recommendation of “Moderate Buy” by the six brokerages that are currently covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, three have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $18.3750.

A number of research firms have recently issued reports on SENS. Weiss Ratings began coverage on shares of Senseonics Holdings, Inc. Common Stock in a research report on Tuesday, February 17th. They issued a “sell (d-)” rating on the stock. Stifel Nicolaus set a $9.00 price target on shares of Senseonics Holdings, Inc. Common Stock in a research report on Tuesday, March 3rd.

Senseonics Holdings, Inc. Common Stock Price Performance

Shares of SENS stock opened at $5.03 on Monday. The firm has a market cap of $210.20 million, a price-to-earnings ratio of -2.52 and a beta of 1.05. The company has a debt-to-equity ratio of 0.58, a quick ratio of 4.55 and a current ratio of 4.83. Senseonics Holdings, Inc. Common Stock has a 1-year low of $4.79 and a 1-year high of $14.50. The business’s fifty day moving average is $6.64.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last posted its quarterly earnings results on Thursday, May 7th. The company reported ($0.71) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.65) by ($0.06). Senseonics Holdings, Inc. Common Stock had a negative return on equity of 111.78% and a negative net margin of 213.87%.The business had revenue of $11.71 million during the quarter. On average, sell-side analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.83 EPS for the current year.

Insider Transactions at Senseonics Holdings, Inc. Common Stock

In other Senseonics Holdings, Inc. Common Stock news, Director Douglas A. Roeder purchased 17,500 shares of Senseonics Holdings, Inc. Common Stock stock in a transaction dated Friday, March 13th. The shares were bought at an average cost of $5.73 per share, for a total transaction of $100,275.00. Following the transaction, the director owned 119,731 shares in the company, valued at $686,058.63. This represents a 17.12% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Timothy T. Goodnow acquired 17,225 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The stock was purchased at an average price of $5.79 per share, for a total transaction of $99,732.75. Following the completion of the transaction, the chief executive officer owned 651,243 shares in the company, valued at $3,770,696.97. The trade was a 2.72% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 4.70% of the company’s stock.

Institutional Trading of Senseonics Holdings, Inc. Common Stock

Several hedge funds have recently bought and sold shares of SENS. First Light Asset Management LLC lifted its position in Senseonics Holdings, Inc. Common Stock by 666.7% in the 2nd quarter. First Light Asset Management LLC now owns 35,708,124 shares of the company’s stock valued at $17,011,000 after purchasing an additional 31,050,619 shares during the last quarter. UBS Group AG lifted its position in Senseonics Holdings, Inc. Common Stock by 409.0% in the 3rd quarter. UBS Group AG now owns 4,248,519 shares of the company’s stock valued at $1,852,000 after purchasing an additional 3,413,866 shares during the last quarter. Geode Capital Management LLC lifted its position in Senseonics Holdings, Inc. Common Stock by 26.6% in the 2nd quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company’s stock valued at $4,147,000 after purchasing an additional 1,828,302 shares during the last quarter. Sei Investments Co. bought a new stake in Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at about $761,000. Finally, Walleye Capital LLC bought a new stake in Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at about $539,000. 12.36% of the stock is currently owned by institutional investors.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc develops and commercializes long-term implantable continuous glucose monitoring (CGM) systems for people with diabetes. The company’s primary product family is the Eversense system, which combines a small subcutaneously implanted sensor, a removable external transmitter, and companion smartphone applications to provide continuous glucose readings and alerts. Senseonics positions its technology as an alternative to wearable patch-style CGMs by offering multi-month sensor longevity and on-body vibration alerts delivered through the transmitter.

Senseonics supports clinical and commercial activities that include research and development, regulatory engagement, manufacturing and distribution, and training for healthcare providers who perform sensor insertion and removal.